Brain Behavior and Immunity,
Journal Year:
2024,
Volume and Issue:
118, P. 167 - 177
Published: Feb. 28, 2024
We
have
previously
shown
that
systemic
inflammation
was
associated
with
post-stroke
cognitive
impairment
(PSCI).
Because
neopterin,
kynurenine
pathway
(KP)
metabolites,
and
B6
vitamers
are
linked
to
inflammation,
in
our
study
we
investigated
whether
those
biomarkers
were
PSCI.
The
Norwegian
Cognitive
Impairment
After
Stroke
is
a
prospective
multicenter
cohort
of
patients
acute
stroke
recruited
from
May
2015
through
March
2017.
Plasma
samples
422
participants
(59
%
male)
ischemic
the
index
hospital
stay
3
months
available
for
analyses
KP
using
liquid
chromatography–tandem
mass
spectrometry.
Mixed
linear
regression
adjusted
age,
sex,
creatinine,
used
assess
there
associations
between
outcomes,
measured
by
Montreal
Assessment
scale
(MoCA)
at
3-,
18-,
36-month
follow-up.
Participants
had
mean
(SD)
age
72
(12)
years,
National
Institutes
Health
Scale
score
2.7
(3.6)
Day
1.
Higher
baseline
values
quinolinic
acid,
PAr
(i.e.,
an
inflammatory
marker
based
on
vitamin
metabolites),
HKr
functional
status
selected
metabolites)
lower
MoCA
3,
18,
36
(p
<
0.01).
concentrations
neopterin
3-hydroxykynurenine
scores
18
months,
higher
xanthurenic
acid
At
post-stroke,
pyridoxal
5́-phosphate
18-
follow-up,
while
picolinic
Biomarkers
metabolites
including
cellular
immune
activation,
indexes
homeostasis,
several
neuroactive
pathway,
Trial
registration:
ClinicalTrials.gov:
NCT02650531.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(2), P. 853 - 853
Published: Jan. 10, 2024
As
the
kynurenine
pathway’s
links
to
inflammation,
immune
system,
and
neurological
disorders
became
more
apparent,
it
attracted
attention.
It
is
main
pathway
through
which
liver
breaks
down
Tryptophan
initial
step
in
creation
of
nicotinamide
adenine
dinucleotide
(NAD+)
mammals.
Immune
system
activation
buildup
potentially
neurotoxic
substances
can
result
from
dysregulation
or
overactivation
this
pathway.
Therefore,
not
shocking
that
kynurenines
have
been
linked
conditions
(Depression,
Parkinson’s,
Alzheimer’s,
Huntington’s
Disease,
Schizophrenia,
cognitive
deficits)
relation
inflammation.
Nevertheless,
preclinical
research
has
demonstrated
are
essential
components
behavioral
analogs
depression
schizophrenia-like
deficits
addition
mediators
associated
with
pathologies
due
their
neuromodulatory
qualities.
Neurodegenerative
diseases
extensively
neuroactive
metabolites
(KP)
tryptophan
breakdown.
In
being
a
necessary
amino
acid
for
protein
synthesis,
also
transformed
into
important
neurotransmitters
tryptamine
serotonin
higher
eukaryotes.
article,
summary
KP,
its
function
neurodegeneration,
approaches
used
currently
target
route
therapeutically
discussed.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(6), P. 3394 - 3394
Published: March 16, 2024
The
central
nervous
system
(CNS)
is
the
final
frontier
in
drug
delivery
because
of
blood–brain
barrier
(BBB),
which
poses
significant
barriers
to
access
most
drugs
their
targets.
Kynurenic
acid
(KYNA),
a
tryptophan
(Trp)
metabolite,
plays
an
important
role
behavioral
functions,
and
abnormal
KYNA
levels
have
been
observed
neuropsychiatric
conditions.
current
challenge
lies
delivering
CNS
owing
its
polar
side
chain.
Recently,
C-3
chain-modified
analogs
shown
cross
BBB;
however,
it
unclear
whether
they
retain
biological
functions
parent
molecule.
This
study
examined
impact
analogs,
specifically,
SZR-72,
SZR-104,
newly
developed
SZRG-21,
on
behavior.
were
administered
intracerebroventricularly
(i.c.v.),
effects
motor
domain
compared
with
those
KYNA.
Specifically,
open-field
(OF)
rotarod
(RR)
tests
employed
assess
activity
skills.
SZR-104
increased
horizontal
exploratory
OF
test
at
dose
0.04
μmol/4
μL,
while
SZR-72
decreased
vertical
doses
0.1
μL.
In
RR
test,
neither
nor
showed
any
differences
skills
either
dose.
Side
chain
modification
affects
affective
performance
behavior,
as
results
show
for
first
time.
this
study,
we
that
alter
emotional
components
such
motor-associated
curiosity
emotions.
Consequently,
design
necessitates
development
precise
strategies
traverse
BBB
paying
close
attention
modifications
Journal of Clinical Investigation,
Journal Year:
2022,
Volume and Issue:
133(2)
Published: Nov. 30, 2022
BACKGROUND.
The
kynurenine
pathway
(KP)
has
been
identified
as
a
potential
mediator
linking
acute
illness
to
cognitive
dysfunction
by
generating
neuroactive
metabolites
in
response
inflammation.
Delirium
(acute
confusion)
is
common
complication
of
and
associated
with
increased
risk
dementia
mortality.
However,
the
molecular
mechanisms
underlying
delirium,
particularly
relation
KP,
remain
elusive.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(11), P. 6300 - 6300
Published: June 4, 2022
Tryptophan
(TRP)
is
an
essential
dietary
amino
acid
that,
unless
otherwise
committed
to
protein
synthesis,
undergoes
metabolism
via
the
Tryptophan-Kynurenine
(TRP-KYN)
pathway
in
vertebrate
organisms.
TRP
and
its
metabolites
have
key
roles
diverse
physiological
processes
including
cell
growth
maintenance,
immunity,
disease
states
coordination
of
adaptive
responses
environmental
cues.
Changes
can
alter
availability
for
serotonin
biosynthesis
as
well
levels
immune-active
KYN
metabolites.
There
now
considerable
evidence
which
has
shown
that
TRP-KYN
be
influenced
by
various
stressors
glucocorticoids
(marker
chronic
stress),
infection,
inflammation
oxidative
stress,
toxicants.
While
there
little
known
regarding
role
following
exposure
contaminants,
linkages
between
chemically
induced
metabolic
perturbations
altered
enzymes
Moreover,
conserved
across
species
xenobiotics,
therefore,
understanding
how
this
regulated
may
broader
implications
wildlife
toxicology.
The
goal
narrative
review
(1)
identify
pathways
affecting
Trp-Kyn
vertebrates
(2)
highlight
consequences
tryptophan
mammals,
birds,
amphibians,
fish.
We
discuss
current
literature
available
species,
gaps
state
knowledge,
further
postulate
kynurenine
ratio
used
a
novel
biomarker
assessing
organismal
and,
more
broadly,
ecosystem
health.
Alzheimer s & Dementia,
Journal Year:
2023,
Volume and Issue:
19(12), P. 5573 - 5582
Published: June 2, 2023
Abstract
INTRODUCTION
The
kynurenine
pathway's
(KP)
malfunction
is
closely
related
to
Alzheimer's
disease
(AD),
for
antagonistic
kynurenic
acid
(KA)
and
agonistic
quinolinic
act
on
the
N
‐methyl‐D‐aspartate
receptor,
a
possible
therapeutic
target
in
treating
AD.
METHODS
In
our
longitudinal
case–control
study,
KP
metabolites
cerebrospinal
fluid
were
analyzed
311
patients
with
AD
105
cognitively
unimpaired
controls.
RESULTS
Patients
exhibited
higher
concentrations
of
KA
(β
=
0.18,
P
<
0.01)
picolinic
0.20,
than
was
positively
associated
tau
pathology
0.29,
0.01),
concentration
slower
progression
dementia.
DISCUSSION
neuroprotective
suggest
that
activation
KP's
branch
an
adaptive
response
may
be
promising
intervention
treatment.
Highlights
(AD)
Higher
Potential
neurotoxic
kynurenines
not
increased
among
Activation
Basic & Clinical Pharmacology & Toxicology,
Journal Year:
2024,
Volume and Issue:
134(5), P. 563 - 573
Published: March 8, 2024
Dementia
is
an
umbrella
term
for
a
broad
group
of
age-associated
neurodegenerative
diseases.
It
estimated
that
dementia
affects
50
million
people
worldwide
and
Alzheimer's
disease
(AD)
responsible
up
to
75%
cases.
Small
extracellular
senile
plaques
composed
filamentous
aggregates
amyloid
β
(Aβ)
protein
tend
bind
neuronal
receptors,
affecting
cholinergic,
serotonergic,
dopaminergic
noradrenergic
neurotransmission,
leading
neuroinflammation,
among
other
pathophysiologic
processes
subsequent
death,
followed
by
dementia.
The
cascade
hypothesis
points
pathological
process
in
the
cleavage
precursor
(APP),
resulting
Aβ.
There
close
relationship
between
pathologies
lead
depression.
depression
prevalent
90%
individuals
diagnosed
with
Parkinson's
disease,
varying
severity,
20
30%
cases
disease.
hypothalamic
pituitary
adrenal
(HPA)
axis
great
intermediary
pathophysiological
mechanisms
diseases
This
review
discusses
role
Aβ
depression,
considering
HPA
axis,
oxidative
stress,
signalling
pathways
neurotransmission.
Behavioural Neurology,
Journal Year:
2023,
Volume and Issue:
2023, P. 1 - 24
Published: Nov. 23, 2023
MicroRNAs
(miRNAs)
are
the
smallest
class
of
noncoding
RNAs,
which
widely
exist
in
animals
and
plants.
They
can
inhibit
translation
or
overexpression
by
combining
with
mRNA
participate
posttranscriptional
regulation
genes,
resulting
reduced
expression
target
proteins,
affecting
development,
growth,
aging,
metabolism,
other
physiological
pathological
processes
It
is
a
powerful
negative
regulator
gene
expression.
mediates
information
exchange
between
different
cellular
pathways
homeostasis
stress
response
regulates
differentiation,
plasticity,
neurotransmission
neurons.
In
neurodegenerative
diseases,
addition
to
complex
interactions
genetic
susceptibility
environmental
factors,
miRNAs
serve
as
promising
diagnostic
tool
for
diseases.
also
increase
reduce
neuronal
damage
regulating
body's
signaling
pathways,
immune
system,
stem
cells,
gut
microbiota,
etc.
not
only
affect
occurrence
diseases
exacerbate
disease
progression
but
promote
repair
apoptosis,
prevent
slow
down
development
This
article
reviews
research
progress
on
mechanism
treatment
nervous
system.
trial
registered
NCT01819545,
NCT02129452,
NCT04120493,
NCT04840823,
NCT02253732,
NCT02045056,
NCT03388242,
NCT01992029,
NCT04961450,
NCT03088839,
NCT04137926,
NCT02283073,
NCT04509271,
NCT02859428,
NCT05243017.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(10), P. 8625 - 8625
Published: May 11, 2023
Rare
ginsenosides
are
the
major
components
of
red
ginseng.
However,
there
has
been
little
research
into
relationship
between
structure
and
their
anti-inflammatory
activity.
In
this
work,
BV-2
cells
induced
by
lipopolysaccharide
(LPS)
or
nigericin,
activity
eight
rare
ginsenosides,
target
proteins
expression
AD
were
compared.
addition,
Morris
water
maze
test,
HE
staining,
thioflavins
urine
metabonomics
used
to
evaluate
effect
Rh4
on
mice.
Our
results
showed
that
configuration
influences
ginsenosides.
Ginsenosides
Rk1,
Rg5,
Rk3,
have
significant
compared
S-Rh1,
R-Rh1,
S-Rg3,
R-Rg3.
S-Rh1
S-Rg3
more
pronounced
than
R-Rh1
R-Rg3,
respectively.
Furthermore,
two
pairs
stereoisomeric
can
significantly
reduce
level
NLRP3,
caspase-1,
ASC
in
cells.
Interestingly,
improve
learning
ability
mice,
cognitive
impairment,
hippocampal
neuronal
apoptosis
Aβ
deposition,
regulate
AD-related
pathways
such
as
tricarboxylic
acid
cycle
sphingolipid
metabolism.
findings
conclude
with
a
double
bond
those
without,
20(S)-ginsenosides
excellent
20(R)-ginsenosides.
Alzheimer s Research & Therapy,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: July 27, 2024
Abstract
Background
Sex
differences
in
neuroinflammation
could
contribute
to
women’s
increased
risk
of
Alzheimer’s
disease
(AD),
providing
rationale
for
exploring
sex-specific
AD
biomarkers.
In
AD,
dysregulation
the
kynurenine
pathway
(KP)
contributes
and
there
is
some
evidence
sex
KP
metabolism.
However,
associations
between
metabolism
biomarkers
need
be
explored
further.
Methods
Here
we
investigate
cerebrospinal
fluid
concentrations
seven
metabolites
with
established
neopterin,
an
indicator
neuroinflammation.
This
study
included
311
patients
symptomatic
105
age-matched
cognitively
unimpaired
(CU)
controls,
followed
up
5
years.
Results
We
found
group,
higher
levels
most
men,
while
were
no
CU
group.
line
this,
more
significantly
altered
men
compared
was
a
trend
same
direction
women.
Furthermore,
kynurenic
acid
acid/quinolinic
ratio
but
clinical
progression.
Discussion
our
cohort,
restricted
patients.
Our
results
suggest
that
due
inflammation